CD8A and neoplasm: Transcription factor NR4a has also been reported to drive Tex via orchestrating epigenetic changes in CD8+ tumor-infiltrating lymphocytes (TIL) and chimeric antigen receptor (CAR) T cells (82, 88, 89).